Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Journal of Medical Genetics
|
October 1, 1990
Two step procedure for early diagnosis of polycystic kidney disease with polymorphic DNA markers on both sides of the gene
M H Breuning, F G Snijdewint, J G Dauwerse, et al.
International Journal of Cancer
|
June 8, 2001
Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients
F G Snijdewint, S von Mensdorff-Pouilly, A H Karuntu-Wanamarta, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 9, 1998
'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence
D J Schol, M F Meulenbroek, F G Snijdewint, et al.
Journal of Medical Genetics
|
October 1, 1990
Map of 16 polymorphic loci on the short arm of chromosome 16 close to the polycystic kidney disease gene (PKD1)
M H Breuning, F G Snijdewint, H Brunner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1995
Functional maturation of human naive T helper cells in the absence of accessory cells. Generation of IL-4-producing T helper cells does not require exogenous IL-4
P Kaliński, C M Hilkens, E A Wierenga, et al.
Cancer Immunology, Immunotherapy : CII
|
May 11, 1999
Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls
F G Snijdewint, S von Mensdorff-Pouilly, A H Karuntu-Wanamarta, et al.
Journal of Clinical Pathology
|
December 1, 2001
MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form
R L ten Berge, F G Snijdewint, S von Mensdorff-Pouilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin
S von Mensdorff-Pouilly, A A Verstraeten, P Kenemans, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
June 27, 2000
Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1
K Ryuko, D J Schol, F G Snijdewint, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 20, 1998
An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1)
S von Mensdorff-Pouilly, M M Gourevitch, P Kenemans, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Journal of Medical Genetics
|
October 1, 1990
Two step procedure for early diagnosis of polycystic kidney disease with polymorphic DNA markers on both sides of the gene
M H Breuning, F G Snijdewint, J G Dauwerse, et al.
International Journal of Cancer
|
June 8, 2001
Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients
F G Snijdewint, S von Mensdorff-Pouilly, A H Karuntu-Wanamarta, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 9, 1998
'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence
D J Schol, M F Meulenbroek, F G Snijdewint, et al.
Journal of Medical Genetics
|
October 1, 1990
Map of 16 polymorphic loci on the short arm of chromosome 16 close to the polycystic kidney disease gene (PKD1)
M H Breuning, F G Snijdewint, H Brunner, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1995
Functional maturation of human naive T helper cells in the absence of accessory cells. Generation of IL-4-producing T helper cells does not require exogenous IL-4
P Kaliński, C M Hilkens, E A Wierenga, et al.
Cancer Immunology, Immunotherapy : CII
|
May 11, 1999
Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls
F G Snijdewint, S von Mensdorff-Pouilly, A H Karuntu-Wanamarta, et al.
Journal of Clinical Pathology
|
December 1, 2001
MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form
R L ten Berge, F G Snijdewint, S von Mensdorff-Pouilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin
S von Mensdorff-Pouilly, A A Verstraeten, P Kenemans, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
June 27, 2000
Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1
K Ryuko, D J Schol, F G Snijdewint, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
May 20, 1998
An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1)
S von Mensdorff-Pouilly, M M Gourevitch, P Kenemans, et al.
Page
of 4